Haemonetics Corp (HAE)

90.82 -0.96 (-1.05%) USD  |  NYSE  |  Nov 14, 16:00
90.82 0.00 (0.00%) After-Hours: 20:00
More

Haemonetics Research and Development Expense (Quarterly): 16.53M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 1994. Upgrade now.
Date Value
September 30, 2024 16.53M
June 30, 2024 14.45M
March 31, 2024 15.86M
December 31, 2023 13.26M
September 30, 2023 12.66M
June 30, 2023 12.65M
March 31, 2023 15.64M
December 31, 2022 12.69M
September 30, 2022 10.90M
June 30, 2022 10.90M
March 31, 2022 13.21M
December 31, 2021 10.04M
September 30, 2021 10.85M
June 30, 2021 12.70M
March 31, 2021 10.84M
December 31, 2020 7.501M
September 30, 2020 6.763M
June 30, 2020 7.75M
March 31, 2020 8.974M
December 31, 2019 7.00M
September 30, 2019 7.422M
June 30, 2019 7.487M
March 31, 2019 8.747M
December 31, 2018 8.978M
September 30, 2018 8.583M
Date Value
June 30, 2018 9.406M
March 31, 2018 11.09M
December 31, 2017 12.43M
September 30, 2017 7.521M
June 30, 2017 8.193M
March 31, 2017 9.321M
December 31, 2016 8.462M
September 30, 2016 8.336M
June 30, 2016 11.44M
March 31, 2016 11.15M
December 31, 2015 10.94M
September 30, 2015 11.55M
June 30, 2015 11.32M
March 31, 2015 17.22M
December 31, 2014 10.64M
September 30, 2014 10.94M
June 30, 2014 15.38M
March 31, 2014 13.84M
December 31, 2013 14.21M
September 30, 2013 14.95M
June 30, 2013 11.21M
March 31, 2013 13.57M
December 31, 2012 10.59M
September 30, 2012 10.83M
June 30, 2012 9.409M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

6.763M
Minimum
Sep 2020
16.53M
Maximum
Sep 2024
11.56M
Average
11.78M
Median

Research and Development Expense (Quarterly) Benchmarks

Boston Scientific Corp 407.00M
Baxter International Inc 129.00M
Globus Medical Inc 35.38M
Becton Dickinson & Co 302.00M
Insulet Corp 54.90M